Radnor Capital Management’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,737
Closed -$49K 340
2024
Q3
$49K Sell
20,737
-1,469
-7% -$2.96K 0.01% 329
2024
Q2
$20K Buy
+22,206
New +$45.8K 0.01% 162

Radnor Capital Management's AUGX Position: Q4 2024 in Review

Radnor Capital Management sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 20,737 shares — an estimated $49K sold.

Radnor Capital Management first reported a position in AUGX in Q2 2024 and held it in 2 quarters. The position peaked at $49K in Q3 2024. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

  • Radnor Capital Management reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Radnor Capital Management sold 20,737 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $49K.
  • Radnor Capital Management first reported a position in Augmedix, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
  • Radnor Capital Management's Augmedix, Inc. Common Stock position peaked at $49K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Radnor Capital Management's 13F filing for Q4 2024, filed 14 Jan 2025.